Compare EIC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIC | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 367.7M |
| IPO Year | N/A | 2021 |
| Metric | EIC | SOPH |
|---|---|---|
| Price | $9.39 | $5.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.63 | $7.00 |
| AVG Volume (30 Days) | ★ 165.8K | 96.2K |
| Earning Date | 02-26-2026 | 03-03-2026 |
| Dividend Yield | ★ 13.82% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.37 | $16.16 |
| Revenue Next Year | $1.08 | $17.56 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.33 | $2.58 |
| 52 Week High | $15.20 | $5.70 |
| Indicator | EIC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 31.06 | 62.48 |
| Support Level | $9.33 | $4.54 |
| Resistance Level | $10.15 | $5.30 |
| Average True Range (ATR) | 0.19 | 0.26 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 10.80 | 87.03 |
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.